Open AccessThe Protective Effect of Human Umbilical Cord Blood CD34+ Cells and Estradiol against Focal Cerebral Ischemia in Female Ovariectomized Rat: Cerebral MR Imaging and Immunohistochemical Study
Author(s) -
Ching Chung Liang,
Ho-Ling Anthony Liu,
Shuenn Dhy Chang,
Sheng Hsien Chen,
Tsong Hai Lee
Publication year - 2016
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0147133
Subject(s) - medicine , cd34 , neuroprotection , ovariectomized rat , ischemia , anesthesia , estrogen , umbilical cord , endocrinology , stem cell , immunology , biology , genetics
Human umbilical cord blood derived CD34 + stem cells are reported to mediate therapeutic effects in stroke animal models. Estrogen was known to protect against ischemic injury. The present study wished to investigate whether the protective effect of CD34 + cells against ischemic injury can be reinforced with complemental estradiol treatment in female ovariectomized rat and its possible mechanism. Experiment 1 was to determine the best optimal timing of CD34 + cell treatment for the neuroprotective effect after 60-min middle cerebral artery occlusion (MCAO). Experiment 2 was to evaluate the adjuvant effect of 17β-estradiol on CD34 + cell neuroprotection after MCAO. Experiment 1 showed intravenous infusion with CD34 + cells before MCAO (pre-treatment) caused less infarction size than those infused after MCAO (post-treatment) on 7T magnetic resonance T2-weighted images. Experiment 2 revealed infarction size was most significantly reduced after CD34 + + estradiol pre-treatment. When compared with no treatment group, CD34 + + estradiol pre-treatment showed significantly less ADC reduction at 2 h and 2 d, less CBF reduction at 2 h and less hyperperfusion at 2 d. The immunoreactivity of c-Fos, c-Jun and GFAP was attenuated, and BDNF showed significant recovery from 2 h to 2 d after MCAO, especially after CD34 + + estradiol pre-treatment. The present study suggests pre-treatment with CD34 + cells with complemental estradiol can be most protective against ischemic injury, which may act through stabilization of cerebral hemodynamics and normalization of the expressions of immediate early genes and BDNF.